menu
    • menu

    Company profile for Boehringer Ingelheim GmbH

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The Boehringer Ingelheim group of companies objectives and believes can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision. Together with our corporate culture concept "Lead & Learn", this vision is the driver of our corporate culture. Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim....
    The Boehringer Ingelheim group of companies objectives and believes can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision. Together with our corporate culture concept "Lead & Learn", this vision is the driver of our corporate culture. Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Boehringer Ingelheim GmbHGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Corporate Division Communications, Binger Strasse 173, 55216 Ingelheim am Rhei...
    Telephone
    Telephone
    +49 - 6132 - 77 0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.boehringer-ingelheim.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/boehringer-ingelheim
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/boehringer

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites   How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control   What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient  

    Impressions: 4930

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

    Radio Compass
    16 Dec 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    BMS, J&J, Bayer lead 25,000+ pharma layoffs in 2024; Amylyx, FibroGen, Kronos Bio hit by trial failures, cash crunch

    BMS, J&J, Bayer lead 25,000+ pharma layoffs in 2024; Amylyx, FibroGen, Kronos Bio hit by trial failures, cash crunch

    Since 2022, there has been a significant surge in layoffs by pharmaceutical and biotech companies. While this trend continued into 2024, the industry showed signs of stabilization in the last four months of the year with the pace of layoffs slowing down. Nonetheless, 2024 was a challenging year. Data compiled by PharmaCompass indicates that over 25,000 layoffs were announced in 2024, driven by economic pressures, failed clinical trials, and strategic pivots. Bristol Myers Squibb and Johnson & Johnson led the layoffs with about 2,300 job cuts each. Bayer announced elimination of 1,800 positions.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 (Free Excel Available) US, Europe, China bear brunt of job cuts; Big Pharma hands pink slips to 10,000 Over 190 biopharma companies announced layoffs in 2024. The year began on a grim note — 27 firms announced significant job cuts in January 2024. By the yearend, Big Pharma alone had contributed more than 10,000 layoffs to the year’s total of over 25,000. Novartis announced over 1,200 job cuts in 2024. It eliminated 330 jobs after it acquired German biotech MorphoSys through the closure of sites in Munich and Boston. Similarly, Bayer announced significant reductions at its US and Swiss facilities.  North America saw increased retrenchments, especially at biotech hubs such as Boston, San Diego, and New Jersey. Massachusetts, with Boston and Cambridge as the epicenter of US biotechnology, saw around 4,000 layoffs, with companies like Relay Therapeutics, Editas Medicine, and Takeda driving the numbers. In San Diego, workforce reductions by Takeda, and Bavarian Nordic collectively resulted in over 900 job losses, significantly impacting the local biotech ecosystem. New Jersey was subject to broader restructuring efforts with BMS and Bayer contributing nearly 1,500 layoffs. The impact in Europe was equally severe. Germany, home to some of the world’s largest pharmaceutical companies, saw over 2,500 layoffs as Bayer and Boehringer Ingelheim scaled back operations. Novartis’ decision to shut down its Munich site added hundreds more to the tally. In Switzerland, Idorsia eliminated 270 positions. Dutch biotech UniQure reduced its workforce by 65 percent (around 300 jobs). That included the sale of a Massachusetts manufacturing facility to Genezen. Denmark also felt the strain, with Leo Pharma cutting 250 roles as part of a strategic revamp. China emerged as another focal point of workforce reductions in 2024. Global pharmaceutical giants, such as Merck and Johnson & Johnson, restructured their operations in response to market complexities in the region. Local companies such as Connect Biopharma, which is transitioning to a US-focused company, also scaled back their presence in the country.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 (Free Excel Available)  Amylyx, FibroGen, Lyra, Athira drastically reduce staff over setbacks in clinical trials Clinical trial failures were one of the most significant drivers of layoffs in 2024. For instance, Amylyx Pharmaceuticals faced a devastating blow when its amyotrophic lateral sclerosis (ALS) therapy, Relyvrio, failed a confirmatory trial. This led to a 70 percent reduction in its workforce, leaving only 100 employees from the 384 full-time staff reported at the end of 2023. The company’s decision to pull the therapy from the market compounded the layoffs. BioMarin Pharmaceutical had to reduce its workforce, as it streamlined its pipeline in response to trial challenges. In August, the company announced a reduction of 225 employees, citing “organizational redesign efforts”. These layoffs followed 170 redundancies announced earlier in May. FibroGen, once considered a leader in oncology drug development, was among the most heavily impacted. The high-profile failure of its anti-CTGF antibody in two late-stage cancer trials led to the discontinuation of its lead candidate, resulting in a 75 percent reduction in its US workforce. Lyra Therapeutics also implemented a 75 percent workforce reduction, affecting 87 employees, after its chronic rhinosinusitis program struggled. Similarly, Athira Pharma cut 70 percent of its team after its Alzheimer’s candidate failed a phase 2/3 trial.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 (Free Excel Available)  Cash crunch, mergers compel Kronos Bio, Editas, Vincerx, Gilead to downsize In addition to clinical failures, funding constraints played a pivotal role in reshaping the biotech landscape. Kronos Bio stood out as one of the hardest-hit firms, cutting 21 percent and 83 percent of its existing workforce in March and November, respectively, as it sought to divest assets and conserve cash. Editas Medicine’s inability to secure partnerships for its sickle cell program forced the company to revert to preclinical research, resulting in a 65 percent workforce reduction. The trend of scaling back R&D pipelines was particularly evident among biotechs struggling to advance preclinical programs to clinical trials. Boundless Bio and Senti Bio exemplified this, choosing to focus on a handful of promising candidates, while reducing discovery efforts. Consolidation often results in overlapping roles, leading to inevitable workforce reductions. Apart from the MorphoSys layoffs by Novartis, Vincerx Pharma faced job losses after it got acquired by Oqory (a clinical-stage ADC company). Vincerx had to cut its workforce by 55 percent.  Amid ongoing reorganization efforts, Gilead closed its Seattle, Washington (US), office and laid off 72 employees of its subsidiary Kite Pharma. Gilead also announced that its Kite facility in Philadelphia, Pennsylvania (US), would close by mid-2025. That was followed by 104 additional layoffs at its California headquarters. In April, it had cut 58 jobs in California. Gilead also announced that its Kite facility in Philadelphia would close by mid-2025. Vir Biotechnology reduced its workforce by 25 percent (i.e. 140 layoffs) to focus on its hepatitis program, and GlycoMimetics let go of 80 percent of its workforce after the FDA demanded an additional clinical trial for its leukemia treatment. Meanwhile, Lexicon Pharmaceuticals reduced its workforce by 60 percent after it stopped commercial operations and transitioned back to being a clinical stage company.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 (Free Excel Available)  Our view It takes decades to build innovation ecosystems. The concentration of layoffs in major biotech hubs has raised concerns about the potential long-term impact on these ecosystems. In 2025, the key challenge will be to maintain the momentum of innovation, as organizations operate with a leaner workforce and a more focused pipeline.  
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 4683

    https://www.pharmacompass.com/radio-compass-blog/bms-j-j-bayer-lead-25-000-pharma-layoffs-in-2024-amylyx-fibrogen-kronos-bio-hit-by-trial-failures-cash-crunch

    #PharmaFlow by PHARMACOMPASS
    16 Jan 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Boehringer Updates Ph 3 Program For Iclepertin In Schizophrenia
    Boehringer Updates Ph 3 Program For Iclepertin In Schizophrenia

    16 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/16/3010915/0/en/Boehringer-provides-update-on-iclepertin-Phase-III-program-in-schizophrenia.html

    GLOBENEWSWIRE
    16 Jan 2025
    Share Share
    Lonza's Synaffix adds Boehringer to partners it with $1.3B ADC pact
    Lonza's Synaffix adds Boehringer to partners it with $1.3B ADC pact

    10 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/lonzas-synaffix-adds-boehringer-ingelheim-its-constellation-partners-1b-adc-technology-pact

    FIERCE BIOTECH
    10 Jan 2025
    Share Share
    Sutro, Boehringer Ingelheim Establish Commercial Cell-Free Tech
    Sutro, Boehringer Ingelheim Establish Commercial Cell-Free Tech

    07 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/07/3005524/0/en/Sutro-Biopharma-and-Boehringer-Ingelheim-BioXcellence-collaboration-Established-first-in-class-cell-free-capabilities-at-commercial-scale.html

    GLOBENEWSWIRE
    07 Jan 2025
    Share Share
    Malaysia Approves Spesolimab for Generalised Pustular Psoriasis
    Malaysia Approves Spesolimab for Generalised Pustular Psoriasis

    13 Dec 2024

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/25/25326/malaysia-gives-nod-to-boehringer-ingelheims-spesolimab-for-treatment-of-generalised-pustular-psoriasis-flares-in-adults.html

    BIOSPECTRUM
    13 Dec 2024
    Share Share
    Boehringer, Lilly bring kidney disease test push to Rose Parade
    Boehringer, Lilly bring kidney disease test push to Rose Parade

    11 Dec 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/boehringer-lilly-bring-it-takes-2-kidney-disease-testing-push-2025-rose-bowl-parade

    FIERCE PHARMA
    11 Dec 2024
    Share Share
    CORE Kidney, Boehringer, Lilly Focus on Kidney Health at Parade
    CORE Kidney, Boehringer, Lilly Focus on Kidney Health at Parade

    09 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/core-kidney-boehringer-ingelheim-and-lilly-are-turning-up-the-volume-on-kidney-health-at-the-2025-tournament-of-roses-parade-302325335.html

    PR NEWSWIRE
    09 Dec 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Epinastine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    Epinastine Hydrochloride

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 15003

    Submission : 2000-09-11

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2011-311 - Rev 01

    Issue Date : 2021-03-17

    Type : Chemical

    Substance Number : 2411

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 224MF10100

    Registrant's Address : Binger Strasse 173,55216 Ingelheim am Rhein

    Initial Date of Registration : 2012-05-23

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Boehringer Ingelheim Korea Ltd.

    Registration Date : 2013-01-09

    Registration Number : 20130109-194-I-63-01

    Manufacturer Name : Boehringer Ingelheim GmbH & Co.KG

    Manufacturer Address : Binger Strasse 173 55216 Ingelheim am Rhein, Germany

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Ipratropium Bromide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    Ipratropium Bromide

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 14259

    Submission : 1999-06-25

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1996-005 - Rev 05

    Issue Date : 2015-10-08

    Type : Chemical

    Substance Number : 919

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 220MF10081

    Registrant's Address : Binger Strasse 173,55216 Ingelheim am Rhein

    Initial Date of Registration : 2008-03-14

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12714-049

    Start Marketing Date : 2011-05-09

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Boehringer Ingelheim Korea Ltd.

    Registration Date : 2012-09-19

    Registration Number : 20120919-188-I-64-01

    Manufacturer Name : Boehringer Ingelheim Pharma GmbH & Co. K.G.

    Manufacturer Address : Binger Strasse 173, 55216 Ingelheim am Rhein

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Repaglinide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    Repaglinide

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 19620

    Submission : 2006-07-24

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2006-123 - Rev 00

    Issue Date : 2012-09-25

    Type : Chemical

    Substance Number : 2135

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 221MF10144

    Registrant's Address : Binger Strasse 173,55216 Ingelheim am Rhein

    Initial Date of Registration : 2009-07-09

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Novo Nordisk Pharmaceuticals Co., Ltd.

    Registration Date : 2021-10-28

    Registration Number : 20211028-209-J-1132

    Manufacturer Name : Boehringer Ingelheim Pharma GmbH & Co KG

    Manufacturer Address : Binger Strasse 173, D-55216 Ingelheim am Rhein, Germany

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Ambroxol Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    Ambroxol Hydrochloride

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2002-142 - Rev 03

    Issue Date : 2011-02-10

    Type : Chemical

    Substance Number : 1489

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 220MF10085

    Registrant's Address : S. S. 11 Padana Superiore,N. 8 24040 Fornovo San Giovanni

    Initial Date of Registration : 2008-03-18

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Opella Healthcare Korea Co., Ltd.

    Registration Date : 2005-08-31

    Registration Number : 20050831-45-B-117-04

    Manufacturer Name : Bidachem SpA

    Manufacturer Address : SS 11(Padana Superiore), 8 24040 Fornovo San Giovanni

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Digoxin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    Digoxin

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 6926

    Submission : 1987-04-06

    Status : Inactive

    Type : II

     CEP/COS Inactive-api
    ✖

    Certificate Number : R1-CEP 2000-147 - Rev 04

    Issue Date : 2015-09-25

    Type : Chemical

    Substance Number : 79

    Status : Withdrawn by Holder

     JDMF arrow-down
    ✖

    Registration Number : 218MF10484

    Registrant's Address : Binger Strasse 173,55216 Ingelheim am Rhein Germany

    Initial Date of Registration : 2006-05-15

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Epinephrine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    Epinephrine

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 5822

    Submission : 1985-05-29

    Status : Inactive

    Type : II

     CEP/COS Inactive-api
    ✖

    Certificate Number : R1-CEP 2009-274 - Rev 00

    Issue Date : 2016-03-17

    Type : Chemical

    Substance Number : 2303

    Status : Withdrawn by Holder

     JDMF arrow-down
    ✖

    Registration Number : 218MF10483

    Registrant's Address : Binger Strasse 173, 55216 Ingelheim am Rhein Germany

    Initial Date of Registration : 2006-05-15

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Ketoprofen

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    Ketoprofen

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 18148

    Submission : 2005-02-21

    Status : Inactive

    Type : II

     CEP/COS Inactive-api
    ✖

    Certificate Number : R1-CEP 2002-010 - Rev 02

    Issue Date : 2010-07-08

    Type : Chemical

    Substance Number : 922

    Status : Withdrawn by Holder

     JDMF arrow-down
    ✖

    Registration Number : 218MF10395

    Registrant's Address : S. S. 11 Padana Superior N. 8 24040 Fornovo S. Giovanni BG Italy

    Initial Date of Registration : 2006-03-20

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Pramipexole Dihydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    Pramipexole Dihydrochloride

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21413

    Submission : 2008-03-12

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2019-186 - Rev 00

    Issue Date : 2020-04-02

    Type : Chemical

    Substance Number : 2416

    Status : Valid

     JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Boehringer Ingelheim Korea Ltd.

    Registration Date : 2022-05-17

    Registration Number : 20220517-209-J-1298

    Manufacturer Name : Boehringer Ingelheim Pharma GmbH & Co. K.G.

    Manufacturer Address : Binger Strasse 173, 55216 Ingelheim am Rhien, Germany

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Salbutamol Sulphate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    Salbutamol Sulphate

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 14258

    Submission : 1999-06-25

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 1997-004 - Rev 05

    Issue Date : 2024-05-30

    Type : Chemical

    Substance Number : 687

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Scopolamine Hydrobromide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    Scopolamine Hydrobromide

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 3622

    Submission : 1979-08-23

    Status : Inactive

    Type : II

     CEP/COS Inactive-api
    ✖

    Certificate Number : R1-CEP 2000-064 - Rev 01

    Issue Date : 2008-09-09

    Type : Chemical

    Substance Number : 106

    Status : Withdrawn by Holder

     JDMF arrow-down
    ✖

    Registration Number : 221MF10105

    Registrant's Address : Binger Strasse 173, 55216 Ingelheim am Rhein

    Initial Date of Registration : 2009-05-27

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    Albuterol Sulfate (unmicronized)

    Germany
    PharmaVenue
    Not Confirmed
    arrow

    02

    Amphetamine Bulk And Dextro Desoxyep...

    Germany
    PharmaVenue
    Not Confirmed
    arrow

    03

    Atropine

    Germany
    PharmaVenue
    Not Confirmed
    arrow

    04

    Atropine Methylnitrate

    Germany
    PharmaVenue
    Not Confirmed
    arrow

    05

    Atropine Sulfate

    Germany
    PharmaVenue
    Not Confirmed
    arrow

    06

    Brompheniramine Maleate

    Germany
    PharmaVenue
    Not Confirmed
    arrow

    07

    Caffeine As Processed In Ingelheim F...

    Germany
    PharmaVenue
    Not Confirmed
    arrow

    08

    Calcium Polycarbophil

    Germany
    PharmaVenue
    Not Confirmed
    arrow

    09

    Camptothecin

    Germany
    PharmaVenue
    Not Confirmed
    arrow

    10

    Chloramphenicol

    U.S.A
    PharmaVenue
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    EDQM

    read-more
    read-more

    01

    GMP Certified

    EU
    PharmaVenue
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PharmaVenue
    Not Confirmed

    Boehringer Ingelheim GmbH

    Type : GMP Certificates

    Number : BE/2011/052

    EudraGMDP Key : 11453

    Country : Germany

    Issue Date :

    Post Code : CEP 06888-700

    NCA Ref : 1.145313243e...

    City : SAO PAULO

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    GMP Certified

    EU
    PharmaVenue
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PharmaVenue
    Not Confirmed

    Boehringer Ingelheim GmbH

    Type : GMP Certificates

    Number : ES/006/ME

    EudraGMDP Key : 14981

    Country : Germany

    Issue Date :

    Post Code : 16090

    NCA Ref : 1.4981135773...

    City : Xochimilco

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    GMP Certified

    EU
    PharmaVenue
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PharmaVenue
    Not Confirmed

    Boehringer Ingelheim GmbH

    Type : GMP Certificates

    Number : VMDGMP/M012...

    EudraGMDP Key : 9201

    Country : Germany

    Issue Date :

    Post Code : 50501

    NCA Ref : 9.2011276701...

    City : Fort Dodge

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    GMP Certified

    EU
    PharmaVenue
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PharmaVenue
    Not Confirmed

    Boehringer Ingelheim GmbH

    Type : GMP Certificates

    Number : VMDGMP/M013...

    EudraGMDP Key : 9200

    Country : Germany

    Issue Date :

    Post Code : 50501

    NCA Ref : 9.20012767e+...

    City : Fort Dodge

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    GMP Certified

    EU
    PharmaVenue
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PharmaVenue
    Not Confirmed

    Boehringer Ingelheim GmbH

    Type : GMP Certificates

    Number : DE_RP_01_GM...

    EudraGMDP Key : 16081

    Country : Germany

    Issue Date :

    Post Code : 16090

    NCA Ref : 12907

    City : Xochimilco, Mexico D.F....

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    GMP Certified

    EU
    PharmaVenue
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PharmaVenue
    Not Confirmed

    Boehringer Ingelheim GmbH

    Type : GMP Certificates

    Number : DE_RP_01_GM...

    EudraGMDP Key : 16351

    Country : Germany

    Issue Date :

    Post Code : 0

    NCA Ref : 12909

    City : Elwood, Kansas

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    GMP Certified

    EU
    PharmaVenue
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PharmaVenue
    Not Confirmed

    Boehringer Ingelheim GmbH

    Type : GMP Certificates

    Number : DE_RP_01_GM...

    EudraGMDP Key : 16374

    Country : Germany

    Issue Date :

    Post Code : 23805

    NCA Ref : 12086

    City : Petersburg, Virginia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    GMP Certified

    EU
    PharmaVenue
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PharmaVenue
    Not Confirmed

    Boehringer Ingelheim GmbH

    Type : GMP Certificates

    Number : DE_RP_01_GM...

    EudraGMDP Key : 24322

    Country : Germany

    Issue Date :

    Post Code : 43228

    NCA Ref : 12085

    City : Columbus, Ohio

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    09

    GMP Certified

    EU
    PharmaVenue
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PharmaVenue
    Not Confirmed

    Boehringer Ingelheim GmbH

    Type : GMP Certificates

    Number : DE_RP_01_GM...

    EudraGMDP Key : 24098

    Country : Germany

    Issue Date :

    Post Code : 06888-700

    NCA Ref : 13239

    City : Itapecerica da Serra - ...

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    10

    GMP Certified

    EU
    PharmaVenue
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PharmaVenue
    Not Confirmed

    Bidachem

    Type : GMP Certificates

    Number : IT-API/99/H...

    EudraGMDP Key : 34291

    Country : Italy

    Issue Date :

    Post Code : 24040

    NCA Ref : 100090

    City : FORNOVO SAN GIOVANNI

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Boehringer Ingelheim Roxane Inc and get a quotation

    Boehringer Ingelheim Roxane Inc is a supplier offers 86 products (APIs, Excipients or Intermediates).

    Find a price of Epinastine Hydrochloride bulk with DMF, CEP, JDMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Ipratropium Bromide bulk with DMF, CEP, JDMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Repaglinide bulk with DMF, CEP, JDMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Digoxin bulk with JDMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Epinephrine bulk with JDMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Pramipexole Dihydrochloride bulk with DMF, CEP offered by Boehringer Ingelheim Roxane Inc

    Find a price of Salbutamol Sulphate bulk with DMF, CEP offered by Boehringer Ingelheim Roxane Inc

    Find a price of Scopolamine Hydrobromide bulk with JDMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Dipyridamole bulk with DMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Hyoscine Butyl Bromide bulk with CEP offered by Boehringer Ingelheim Roxane Inc

    Find a price of Tiotropium Bromide bulk with CEP offered by Boehringer Ingelheim Roxane Inc

    Find a price of Atropine bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Atropine Sulfate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Brotizolam bulk with CEP offered by Boehringer Ingelheim Roxane Inc

    Find a price of Clenbuterol Hydrochloride bulk with CEP offered by Boehringer Ingelheim Roxane Inc

    Find a price of Clonidine bulk with CEP offered by Boehringer Ingelheim Roxane Inc

    Find a price of Dihydroergotamine Mesylate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Epinephrine Bitartrate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Ergotamine Tartrate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Etilefrine bulk with CEP offered by Boehringer Ingelheim Roxane Inc

    Find a price of Fenoterol Hydrobromide bulk with CEP offered by Boehringer Ingelheim Roxane Inc

    Find a price of Homatropine Hydrobromide bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Homatropine Methylbromide bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Hyoscyamine Sulfate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Methocarbamol bulk with DMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Methylphenidate Hydrochloride bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Moxonidine bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Phenylephrine Hydrochloride bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Pramipexole Dihydrochloride bulk with CEP offered by Boehringer Ingelheim Roxane Inc

    Find a price of Scopolamine bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Tramazoline Hydrochloride Monohydrate bulk with CEP offered by Boehringer Ingelheim Roxane Inc

    Find a price of Trospium Chloride bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Zolpidem Tartrate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Medium / Medium Additives / G-Medium bulk with JDMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Medium / Medium Additives-I-Medium bulk with JDMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Medium / Medium Additives ・ F-Media bulk with JDMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Medium / Medium Additives-P-Media bulk with JDMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Beperuminogen per plasmid bulk with JDMF offered by Boehringer Ingelheim Roxane Inc

    Find a price of Amphetamine bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Beta-2 bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Brompheniramine Maleate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Caffeine bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Calcium Polycarbophil bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Camptothecine bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Crotamiton bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Dexrazoxane bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Digoxin bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Dihydroergotoxine Mesylate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Doxapram Hydrochloride bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Esmolol Hydrochloride bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Fentanyl bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Fentanyl Citrate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Glycopyrronium Bromide bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Guaifenesin bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Isoproterenol Hydrochloride bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of L-Lactide bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Lanthanum Carbonate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Lobeline Sulfate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Meloxicam bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Metaproterenol Hemisulfate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Metaxalone bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Methadol Hydrochloride bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Methadone Hydrochloride bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Methscopolamine Bromide bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Methscopolamine Nitrate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Metoclopramide bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Milrinone bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Physostigmine Salicylate bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Pilocarpine Hydrochloride bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Ranitidine Hydrochloride bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Scopolamine Hydrobromide bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Theophylline bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Tiotropium Bromide bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Yohimbine Hydrochloride bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of PRODUCTION AND DISTRIBUTION FACILITY IN DANBURY, CONNECTICUT bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of NR-LU-10 MURINE MONOCLONAL ANTIBODY FAB FRAGMENT (NOFETUMOMAB) AND PHENTHIOATE LIGAND BULK MATERIAL FOR ONCOTRAC KIT (NEORX) bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of COPOLYMERS OF TRIMETHYLENE CARBONATE WITHL- OR D,L-LACTIDE bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN RIDGEFIELD, CONNECTICUT. bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of rTNF-alpha Drug Substance bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of IFN-OMEGA bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of POLY-(D,L-LACTIDE-CO-GLYCOLIDE) 50:50 bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of PHYSOSTIGMINE SALICYLATE (SYNTHETIC bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of INTERLEUKIN-12 BULK SUBSTANCE bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of ESERETHOL bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Bromhexine Hydrochloride bulk offered by Boehringer Ingelheim Roxane Inc

    Find a price of Penethamate Hydriodide bulk offered by Boehringer Ingelheim Roxane Inc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search